Global (AMER, APAC, BRICS and EMEA) Therapeutic Nuclear Medicines Market Research Report 2019-2025 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Therapeutic Nuclear Medicines Market



Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy. Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain. Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy. In 2019, the market size of Therapeutic Nuclear Medicines is 1008.9 million US$ and it will reach 3213.8 million US$ in 2025, growing at a CAGR of 18.0% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Therapeutic Nuclear Medicines. This report studies the global market size of Therapeutic Nuclear Medicines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Therapeutic Nuclear Medicines production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019. 

Market Segmentation, Outlook & Regional Insights: Therapeutic Nuclear Medicines Market

Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Radium-223
Lutetium-177
Iodine-131
Other

Segmentation by Application : Breakdown of data from year 2014 to 2019 and forecast until 2025:

Thyroid
Bone Metastasis
Lymphoma
Other

Key Players, Recent Developments & Sector Viewpoints: Therapeutic Nuclear Medicines Market
  
Bayer
Novartis AG
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes

Key Insights Covered: Exhaustive Therapeutic Nuclear Medicines Market
1.  Market size (sales, revenue and growth rate) of Therapeutic Nuclear Medicines industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Therapeutic Nuclear Medicines industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Therapeutic Nuclear Medicines industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Therapeutic Nuclear Medicines industry.

Research Methodology: Therapeutic Nuclear Medicines Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.